Melo C. De Pinho Pessoa

Fortaleza, CE, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Deciphering the circadian signature in acute myeloid leukemia: NPAS2 downregulation as a master predictive feature.

Deciphering the circadian signature in acute myeloid leukemia: NPAS2 downregulation as a master predictive feature.

Journal: Blood research
Published: February 28, 2026

Synergistic Effect of Antimicrobial Resistance and Cytogenetic Risk on Mortality in Acute Myeloid Leukemia.

Synergistic Effect of Antimicrobial Resistance and Cytogenetic Risk on Mortality in Acute Myeloid Leukemia.

Journal: Anticancer research
Published: April 16, 2025

WRAP53 is Downregulated in Acute Myeloid Leukemia Patients and Positively Correlates With HTERT Expression.

WRAP53 is Downregulated in Acute Myeloid Leukemia Patients and Positively Correlates With HTERT Expression.

Journal: Cancer reports (Hoboken, N.J.)
Published: April 16, 2025

Evaluation of the Circadian Rhythm Component Cipc (Clock-Interacting Pacemaker) in Leukemogenesis: A Literature Review and Bioinformatics Approach.

Evaluation of the Circadian Rhythm Component Cipc (Clock-Interacting Pacemaker) in Leukemogenesis: A Literature Review and Bioinformatics Approach.

Journal: Clocks & sleep
Published: February 14, 2025

Hyperexpression of PTAFR and PF4 as Possible Platelet Risk Biomarkers in Patients With COVID-19.

Hyperexpression of PTAFR and PF4 as Possible Platelet Risk Biomarkers in Patients With COVID-19.

Journal: In vivo (Athens, Greece)
Published: July 04, 2024

Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With BCR::ABL1 p190+ Translocation.

Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With BCR::ABL1 p190+ Translocation.

Journal: Cancer diagnosis & prognosis
Published: May 22, 2024

Association of CD38+ Immunophenotyping Biomarker With a Better Prognosis in Elderly Acute Myeloid Leukemia Patients.

Association of CD38+ Immunophenotyping Biomarker With a Better Prognosis in Elderly Acute Myeloid Leukemia Patients.

Journal: Anticancer research
Published: April 08, 2024

Molecular and Clinical Insights in the Increasing Detection of BCR::ABL1 p190+ in Adult Acute Myeloid Leukemia Patients.

Molecular and Clinical Insights in the Increasing Detection of BCR::ABL1 p190+ in Adult Acute Myeloid Leukemia Patients.

Journal: In vivo (Athens, Greece)
Published: March 06, 2024

Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.

Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.

Journal: Cancer diagnosis & prognosis
Published: October 15, 2023

Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising Biomarkers.

Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising Biomarkers.

Journal: International journal of molecular sciences
Published: June 17, 2022

Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution.

Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution.

Journal: International journal of molecular sciences
Published: February 26, 2022

Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations.

Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations.

Journal: Pharmaceutics
Published: August 29, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026